A tiered approach to regulatory studies seems highly desirable, with the selection of an
initial ‘core’ list of tests and the use of additional tests where these are required to further
characterize toxicity. Core tests should include general measurements of the common
target organs, e.g. plasma urea and creatinine for renal injury and several plasma enzymes
for hepatic injury.